These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 180446)

  • 1. In vitro release of ACTH from dispersed rat pars intermedia cells. I. Effect of secretagogues.
    Kraicer J; Morris AR
    Neuroendocrinology; 1976; 20(1):79-96. PubMed ID: 180446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro regulation of ACTH release from neurointermediate lobe of rat hypophysis. I. Effect of crude hypothalamic extracts.
    Briaud B; Koch B; Lutz-Bucher B; Mialhe C
    Neuroendocrinology; 1978; 25(1):47-63. PubMed ID: 206849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro release of ACTH from dispersed rat pars intermedia cells. II. Effect of neurotransmitter substances.
    Kraicer J; Morris AR
    Neuroendocrinology; 1976; 21(2):175-92. PubMed ID: 13323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro release of ACTH from dispersed rat pars intermedia cells. III. Multiple forms of ACTH biological activity.
    Kraicer J; Elliot NL; Zimmerman AE
    Neuroendocrinology; 1978; 27(1-2):86-96. PubMed ID: 215929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of calcium ions in the release of ACTH from rat pituitary tissue in vitro.
    Zimmerman G; Fleischer N
    Endocrinology; 1970 Aug; 87(2):426-9. PubMed ID: 4316575
    [No Abstract]   [Full Text] [Related]  

  • 6. Physical characteristics of the Ca++ compartments associated with in vitro ACTH release.
    Milligan JV; Kraicer J
    Endocrinology; 1974 Feb; 94(2):435-43. PubMed ID: 4359127
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of in vivo and in vitro corticotropin-releasing hormone-stimulated release of proopiomelanocortin-derived peptides in cats.
    Willemse T; Mol JA
    Am J Vet Res; 1994 Dec; 55(12):1677-81. PubMed ID: 7887510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man.
    Lamberts SW; Verleun T; Oosterom R; de Jong F; Hackeng WH
    J Clin Endocrinol Metab; 1984 Feb; 58(2):298-303. PubMed ID: 6319446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-melanocyte stimulating hormone release in response to thyrotropin releasing hormone in healthy horses, horses with pituitary pars intermedia dysfunction and equine pars intermedia explants.
    McFarlane D; Beech J; Cribb A
    Domest Anim Endocrinol; 2006 May; 30(4):276-88. PubMed ID: 16115743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation and secretion of proopiomelanocortin peptides from isolated perifused dog pituitary pars intermedia cells.
    Kemppainen RJ; Zerbe CA; Sartin JL
    Endocrinology; 1989 May; 124(5):2208-17. PubMed ID: 2539971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of pro-opiomelanocortin-derived peptides from the pars intermedia and pars distalis of the rat pituitary: effect of corticotrophin-releasing factor and somatostatin.
    Kraicer J; Gajewski TC; Moor BC
    Neuroendocrinology; 1985 Nov; 41(5):363-73. PubMed ID: 2865690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of bioactive corticotropin release from the neuro-intermediate lobe of the rat pituitary in vitro.
    Fischer JL; Moriarty CM
    Endocrinology; 1977 Apr; 100(4):1047-54. PubMed ID: 189989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the corticotrophin-releasing activity of vasopressin, using ACTH secretion by cultured rat adenohypophyseal cells.
    Yasuda N; Greer MA
    Endocrinology; 1976 Apr; 98(4):936-42. PubMed ID: 179790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary 45 Ca ion uptake and release of ACTH, GH, and TSH: effect of verapamil.
    Eto S; Wood JM; Hutchins M; Fleischer N
    Am J Physiol; 1974 Jun; 226(6):1315-20. PubMed ID: 4365294
    [No Abstract]   [Full Text] [Related]  

  • 15. Involvement of vasopressin in corticotropin-releasing effect of hypothalamic median eminence extract.
    Lutz-Bucher B; Koch B; Mialhe C; Briaud B
    Neuroendocrinology; 1980; 30(3):178-82. PubMed ID: 6245385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two distinct corticotrophin releasing activities of vasopressin.
    Buckingham JC
    Br J Pharmacol; 1985 Jan; 84(1):213-9. PubMed ID: 2983801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia.
    Engler D; Pham T; Fullerton MJ; Ooi G; Funder JW; Clarke IJ
    Neuroendocrinology; 1989 Apr; 49(4):367-81. PubMed ID: 2541360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis.
    Swain MG; Patchev V; Vergalla J; Chrousos G; Jones EA
    J Clin Invest; 1993 May; 91(5):1903-8. PubMed ID: 8387536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro studies on corticotropin releasing activity of vasopressin and hypothalamic median eminence extract.
    Lutz-Bucher B; Koch B; Mialhe C
    Neuroendocrinology; 1977; 23(3):181-92. PubMed ID: 197442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin-releasing hormone does not alter the release of melanocyte-stimulating hormone or adrenocorticotropic hormone from the rat pars intermedia.
    Kraicer J
    Neuroendocrinology; 1977; 24(3-4):226-31. PubMed ID: 204881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.